Primary Recipient

PLX PHARMA INC

Amount

$37,500.00

Award Date

1/26/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

PLx Pharma is a pharmaceutical company developing GI safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs) including ibuprofen, aspirin and naproxen for prescription and over-the-counter markets. PLx has created novel NSAID formulati